BOSTON, March 30, 2026 -- Aktis Oncology, Inc. (NASDAQ:AKTS) (the “Company”), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large populations, including those not...
Arthur Klausner to sit on the "VC Check-Up" panel at the "Life Sciences & Healthcare Venture Summit 2008" in New York City
News | 10. 30. 2008
